ASVRX
Price
$10.57
Change
+$0.09 (+0.86%)
Updated
Jan 30 closing price
Net Assets
5.36B
PEVAX
Price
$16.97
Change
+$0.20 (+1.19%)
Updated
Jan 30 closing price
Net Assets
N/A
Ad is loading...

ASVRX vs PEVAX

Header iconASVRX vs PEVAX Comparison
Open Charts ASVRX vs PEVAXBanner chart's image
American Century Small Cap Value R
Price$10.57
Change+$0.09 (+0.86%)
VolumeN/A
Net Assets5.36B
PACE Small/Medium Co Value Equity A
Price$16.97
Change+$0.20 (+1.19%)
VolumeN/A
Net AssetsN/A
ASVRX vs PEVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASVRX vs. PEVAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a StrongBuy and PEVAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
ASVRX (0.47) and PEVAX (0.46) have matching dividends . ASVRX was incepted earlier than PEVAX: ASVRX (15 years) vs PEVAX (24 years). ASVRX is a more actively managed with annual turnover of: 44.00 vs. PEVAX (36.00). PEVAX has a lower initial minimum investment than ASVRX: PEVAX (1000) vs ASVRX (2500). ASVRX annual gain was more profitable for investors over the last year : 9.91 vs. PEVAX (-4.73). ASVRX return over 5 years is better than : 44.16 vs. PEVAX (-8.90).
ASVRXPEVAXASVRX / PEVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years24 years-
Gain YTD4.2412.883147%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets5.36BN/A-
Annual Yield % from dividends0.470.46102%
Returns for 1 year9.91-4.73-209%
Returns for 3 years5.43-22.92-24%
Returns for 5 years44.16-8.90-496%
Returns for 10 years24.89-9.65-258%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGGDX28.670.87
+3.13%
First Eagle Gold A
PAEIX13.220.16
+1.23%
T. Rowe Price Overseas Stock Advisor
BRULX16.030.13
+0.82%
MFS Blended Research Value Equity R3
LPFCX5.76N/A
N/A
ALPS Global Opportunity C
AWMIX20.59N/A
N/A
CIBC Atlas Mid Cap Equity Institutional